EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low Expression of UBE2Z, a Target Protein of miR-500a, Is Associated with Poor Prognosis in Triple-Negative Breast Cancer

Donghyun Kim iD, Song-Yi Choi

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Donghyun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea. Hauptthemen laut MEDLINE: MicroRNAs, Triple Negative Breast Neoplasms, Ubiquitin-Conjugating Enzymes, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) exhibits diverse histological and molecular characteristics. TNBC patients also have the poorest prognoses among those with various breast cancer subtypes, and no effective treatment strategy has been established for TNBC beyond non-specific chemotherapy. Recent studies have reported that the dysregulation of miRNAs is associated with tumor behavior, prognosis, and treatment responses in TNBC patients. Therefore, this study was conducted to identify miRNAs and key target proteins potentially associated with TNBC prognosis. Fresh-frozen tissue from relapsing and non-relapsing TNBC cases was examined for differentially expressed miRNAs using the Affymetrix GeneChip miRNA 4.0 array, while target genes and proteins were predicted using the miRwalk 2.0 database. The clinical significance of each differentially expressed miRNA was evaluated using the BreastMark database. Additional bioinformatics analyses were conducted to reveal associations with tumor-related signaling pathways; these analyses included protein–protein interaction network construction and Kyoto Encyclopedia of Genes and Genomes pathway annotation. Gene chip analysis identified three upregulated miRNAs (miR-500a, miR-501-3p, and miR-502-3p) and two downregulated miRNAs (miR-6798-5p and miR-7150) in patients with recurrence, and further bioinformatics analyses revealed that target proteins were significantly associated with cell cycle pathways. In addition, low expression of the miR-500a target protein UBE2Z was significantly associated with a poor prognosis. The expression levels of miR-500a and UBE2Z might be useful prognostic biomarkers in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsTriple Negative Breast NeoplasmsUbiquitin-Conjugating EnzymesGene Expression Regulation, NeoplasticHumansPrognosisFemaleGene Expression ProfilingBiomarkers, TumorProtein Interaction MapsComputational Biology

Stichwörter der Autor:innen

UBE2ZmicroRNAstriple-negative breast cancer

Substanzen

MicroRNAsUbiquitin-Conjugating EnzymesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.

ORCID-Profile: Donghyun Kim

Zitieren

APA

Kim, D., & Choi, S. Y. (2025). Low Expression of UBE2Z, a Target Protein of miR-500a, Is Associated with Poor Prognosis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010361

Vancouver

Kim D, Choi SY. Low Expression of UBE2Z, a Target Protein of miR-500a, Is Associated with Poor Prognosis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010361

BibTeX
@article{Kim2025,
  author = {Kim, Donghyun and Choi, Song-Yi},
  title = {Low Expression of UBE2Z, a Target Protein of miR-500a, Is Associated with Poor Prognosis in Triple-Negative Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010361}
}
Kostenlos starten →